Lexicon Pharmaceuticals LXRX Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's comprehensive income (loss), net of tax, attributable to parent?
- Lexicon Pharmaceuticals (LXRX) reported comprehensive income (loss), net of tax, attributable to parent of -$1.2M in Q1 2026.
- How has Lexicon Pharmaceuticals's comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Lexicon Pharmaceuticals's comprehensive income (loss), net of tax, attributable to parent increased by 95.3% year-over-year, from -$25.39M to -$1.2M.
- What is the long-term trend for Lexicon Pharmaceuticals's comprehensive income (loss), net of tax, attributable to parent?
- Over 4 years (2021 to 2025), Lexicon Pharmaceuticals's comprehensive income (loss), net of tax, attributable to parent has grown at a -12.9% compound annual growth rate (CAGR), from -$87.76M to -$50.43M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- A comprehensive measure of financial performance that includes net income plus other gains and losses that bypass the traditional income statement. It provides a broader view of the company's total change in equity from non-owner sources.